NIH director expects booster injections to be extended, despite recommendation from FDA advisers



[ad_1]

Francis Collins, director of the National Institutes of Health (NIH), said on Sunday it would “surprise” him if the COVID-19 recall was not extended, despite a recommendation from a panel of the Food and Drug Administration (FDA ) advising against generalized use.

“I think the big news is that they actually approved the launch of the boosters and remember that they’re taking a snapshot right now. We’ll see what happens in the weeks to come,” Collins said during of her appearance on “Fox News Sunday.” “It would surprise me if it did not become clear over the next few weeks that the administration of recalls may need to be expanded.”

“Based on the data that we have already seen in the United States and Israel, it is clear that the decrease in the effectiveness of these vaccines is a reality, and we must respond to it,” he added.

On Friday, an advisory group voted to recommend that the FDA authorize a third booster of Pfizer’s COVID-19 vaccine for people over 65 and others at high risk of COVID-19. However, the panel voted against recommending a booster injection for all people over 16.

At the request of the host Chris WallaceChristopher (Chris) WallaceBiden’s vaccine tenure puts McConnell, GOP leaders in dire straits’ MORE Sunday if he felt that a reminder would still be needed for everyone, Collins was not sure it was needed for “absolutely everyone” but reiterated that he would be “surprised” if the reminders were not. not recommended for people under 65 in the coming weeks.

“What you see here is that science is happening in a very transparent way. This is the way it should be,” Collins added.

“I’m a little confused that people are complaining that the process isn’t working for them. The process is to look at the data for experts to review, and then make their best judgment at this point, recognizing that judgments can make money. “



[ad_2]

Source link